Ionis Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030

Updated on 03/29/2024

Stock Rating
9
Price Target
$61.00
Consensus
Outperform
Upside
41.01%
Analysts
3
Stock Rating
9
Upside
41.01%
Analysts
3
Price Target
$61.00

Ionis Pharmaceuticals Stock Forecast and Price Target

The average price target of $61.00 for Ionis Pharmaceuticals's stock set by three distinguished analysts in recent weeks would represent a potential upside of approximately 41.01% from the last closing price in March, 2024 if reached by the end of the year. This potential increase is based on a high estimate of $85.00 and a low estimate of $29.00. If you are interested in IONS stock, it is important to also consider its competitors.

$61.00

41.01% Upside

Outperform
Outperform

Ionis Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Ionis Pharmaceuticals's Price has grown, moving from $0.00 to $0.00 – an increase of 100.00%. In the next year, analysts predict that Fair Value will jump to $46.93 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that Fair Value will grow by 100.00%.

2024 Fair Value Forecast
$46.93
2025 Fair Value Forecast
$52.18
2026 Fair Value Forecast
$58.02
2027 Fair Value Forecast
$64.51
2028 Fair Value Forecast
$71.73
2029 Fair Value Forecast
$79.75
2030 Fair Value Forecast
$88.68
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
PFE Stock Forecast Pfizer Outperform 2
$28.37 Buy/Sell $32.87 10.82%
AMGN Stock Forecast Amgen Outperform 4
$275.36 Buy/Sell $303.65 14.40%
SAN Stock Forecast Sanofi Outperform 16
88.32€ Buy/Sell 102.80€ 21.15%
REGN Stock Forecast Regeneron Pharmaceuticals Outperform 2
$964.44 Buy/Sell $961.26 8.87%
CSL Stock Forecast CSL Outperform 12
$281.20 Buy/Sell $205.51 -27.94%

Ionis Pharmaceuticals Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Ionis Pharmaceuticals's Revenue has grown, moving from $729.26M to $787.65M – an increase of 8.01%. In the following year, the 14 analysts surveyed believe that Ionis Pharmaceuticals's Revenue will decrease by 22.19%, reaching $612.87M. Looking ahead to seven years, experts forecast that Revenue will grow by 339.35%.

2024 Rev Forecast
$0.61B
2025 Rev Forecast
$0.97B
2026 Rev Forecast
$1.22B
2027 Rev Forecast
$1.54B
2028 Rev Forecast
$2.45B
2029 Rev Forecast
$2.96B
2030 Rev Forecast
$3.46B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
4568 Stock Forecast Daiichi Sankyo Company Buy 4
¥4.83k Buy/Sell ¥5.24k 18.04%
4502 Stock Forecast Takeda Pharmaceutical Company Outperform 5
¥4.31k Buy/Sell ¥4.74k 6.63%
MRNA Stock Forecast Moderna Outperform 16
$111.98 Buy/Sell $135.42 11.09%

Ionis Pharmaceuticals Dividend per Share Forecast for 2023 - 2025 - 2030

2024 DPS Forecast
$0.00
2025 DPS Forecast
$0.00
2026 DPS Forecast
$0.00
2027 DPS Forecast
$0.00
2028 DPS Forecast
$0.00
2029 DPS Forecast
$0.00
2030 DPS Forecast
$0.00
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BIIB Stock Forecast Biogen Outperform 10
$230.07 Buy/Sell $299.62 29.09%
ALNY Stock Forecast Alnylam Pharmaceuticals Inc Outperform 7
$149.10 Buy/Sell $245.24 44.20%
BMRN Stock Forecast BioMarin Pharmaceutical Outperform 10
$86.00 Buy/Sell $111.56 26.40%

Ionis Pharmaceuticals Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
$-329030000.00
2025 FCF Forecast
$-64770000.00
2026 FCF Forecast
$0.38B
2027 FCF Forecast
$0.84B
2028 FCF Forecast
$1.14B
2029 FCF Forecast
$0.84B
2030 FCF Forecast
$0.97B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
INCY Stock Forecast Incyte Outperform 9
$60.79 Buy/Sell $77.05 26.99%
SRPT Stock Forecast Sarepta Therapeutics Outperform 6
$121.58 Buy/Sell $158.66 35.71%
JAZZ Stock Forecast Jazz Pharmaceuticals Outperform 14
$116.63 Buy/Sell $188.32 59.52%

Ionis Pharmaceuticals EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, EBITDA for Ionis Pharmaceuticals has grown by 167.29%, going from $-126.91M to $-339.22M. For the next year, 3 analysts project Ionis Pharmaceuticals's EBITDA to drop by 16.25%, reaching $-284.11M. By 2030, professionals believe that Ionis Pharmaceuticals's EBITDA will decrease by 51.09%, reaching $-165.90M – a concerning trend for the company.

2024 EBITDA Forecast
$-284110000.00
2025 EBITDA Forecast
$-114700000.00
2026 EBITDA Forecast
$-109130000.00
2027 EBITDA Forecast
$-171770620.00
2028 EBITDA Forecast
$-238377540.75
2029 EBITDA Forecast
$-191250300.94
2030 EBITDA Forecast
$-165896886.05
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
EXEL Stock Forecast Exelixis Outperform 16
$22.46 Buy/Sell $26.44 20.21%
NTLA Stock Forecast Intellia Therapeutics Outperform 8
$29.54 Buy/Sell $75.84 136.97%
4516 Stock Forecast Nippon Shinyaku Outperform 18
¥4.56k Buy/Sell ¥8.34k 64.62%

Ionis Pharmaceuticals EBIT Forecast for 2023 - 2025 - 2030

Ionis Pharmaceuticals's EBIT has grown in the last three years, jumping from $-142.33M to $-352.07M – an increase of 147.36%. In the next year, analysts predict that EBIT will reach $-453.93M – an increase of 28.93%. By 2030, professionals believe that Ionis Pharmaceuticals's EBIT will decrease by 564.73%, reaching $1.64B – a concerning trend for the company.

2024 EBIT Forecast
$-453930000.00
2025 EBIT Forecast
$-193770000.00
2026 EBIT Forecast
$-48310000.00
2027 EBIT Forecast
$0.34B
2028 EBIT Forecast
$0.93B
2029 EBIT Forecast
$1.28B
2030 EBIT Forecast
$1.64B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
DYN Stock Forecast Dyne Therapeutics Buy 5
$25.55 Buy/Sell $28.13 40.90%
DCPH Stock Forecast Deciphera Pharmaceuticals Outperform 6
$16.54 Buy/Sell $23.40 39.06%
BCRX Stock Forecast BioCryst Pharmaceuticals Outperform 7
$5.32 Buy/Sell $14.09 97.37%

Ionis Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Ionis Pharmaceuticals's EPS has grown, moving from $-0.35 to $0.00 – an increase of 100.00%. In the next year, analysts predict that EPS will jump to $-1.88 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that EPS will grow by 100.00%.

2024 EPS Forecast
$-1.88
2025 EPS Forecast
$-0.57
2026 EPS Forecast
$1.02
2027 EPS Forecast
$9.21
2028 EPS Forecast
$12.33
2029 EPS Forecast
$12.38
2030 EPS Forecast
$6.98
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
WVE Stock Forecast Wave Life Sciences Outperform 6
$6.80 Buy/Sell $9.21 61.76%
PHARM Stock Forecast Pharming Group N.V. Buy 16
1.07€ Buy/Sell 1.85€ 66.36%
FULC Stock Forecast Fulcrum Therapeutics Outperform 9
$11.28 Buy/Sell $10.21 32.98%